<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>RYNEZE LIQUID- chlorpheniramine maleate and methscopolamine nitrate liquid </strong><br>SJ Pharmaceuticals, LLC<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Ryneze Liquid</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>DESCRIPTION:</h1>
<p class="First"></p>
<p>Each
teaspoonful (5 mL) for oral administration
contains:<br>Chlorpheniramine
Maleate ...................................... 4 mg<br>Scopolamine
Methyl Nitrate .............................. 1.25 mg</p>
<p></p>
<p><span class="Bold">INACTIVE
INGREDIENTS: </span>Citric Acid, Grape flavor, Glycerin, Propylene
Glycol, Purified Water, Sodium Citrate, Sodium<br>Saccharin,
and Sorbitol.</p>
<p>RYNEZE®
LIQUID contains ingredients from the following classes:
antihistamine, and anticholinergic.</p>
<p></p>
<p>Chlorpheniramine
Maleate is an antihistamine with the chemical
name: 2-Pyridinepropanamine, <span>γ</span>-(4-chlorphenyl)-<br><span class="Italics">N,N</span>-dimethyl-,
(Z)-2-butenedioate (1:1), and has the following
chemical structure:</p>Chlorpheniramine
Maleate structure:<br><br><div class="Figure"><img alt="Chlorpheniramine Maleate structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9aca3d25-d042-479b-a00e-63be5b5073fe&amp;name=MM8.jpg"></div>
<br><p></p>
<p></p>
<p>Scopolamine
Methyl Nitrate is an anticholinergic belldonna alkaloid
derivative with the chemical name:<br>[7(s)-(<span>α</span><span>,2<span>β,</span>4<span>β</span>,5<span>α</span>,7<span>β</span>,)]–7–(3–hydroxy–1-oxo – 2- Phenylpropoxy)-9,
9-dimethyl–3-oxa– 9-azoniatricyclo<br>[3.3.1.0
2,4] nonane nitrate.It
has the following chemical structure:</span></p>Scopolamine
Methyl Nitrate:<br><br><div class="Figure"><img alt="Scopolamine Methyl Nitrate" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9aca3d25-d042-479b-a00e-63be5b5073fe&amp;name=MM9.jpg"></div>
<br><p><span><br></span></p>
<p></p>
<p></p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY:</h1>
<p class="First">Chlorpheniramine
maleate competitively antagonizes most of the
smooth muscle stimulating actions of histamine on the<br>H1
receptors of the GI tract, uterus, large blood vessels, and bronchial
muscle. It also antagonizes the action of histamine<br>that
results in increased <span class="product-label-link" type="condition" conceptid="4023793" conceptname="Capillary permeability">capillary permeability</span> and the formation
of <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>. Chlorpheniramine maleate is analkylamine-type
antihistamine. <br>This group of antihistamines are
among the most active histamine antagonists and are<br>generally
effective in relatively low doses. They thereby prevent,
but do not reverse, responses mediated by histamine<br>alone.
The anticholinergic actions of most antihistamines provide
a drying effect on the nasal mucosa. These drugs are<br>not
so prone to produce <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> and are among the most suitable
agents for daytime use, but a significant proportion<br>of
patients do experience this effect.</p>
<p>Scopolamine
methyl nitrate is one of the principal anticholinergic/antispasmodic
components of belladonna<br>alkaloids
that exhibits antisecretory activity. Scopolamine methyl
nitrate inhibits the muscarinic actions of acetylcholine<br>on
structures innervated by postganglionic cholinergic nerves:
smooth muscle, cardiac muscle, sinoatrial and<br>atrioventricular
nodes, and exocrine glands. In general, the smaller
doses of anticholinergics inhibit salivary and<br>bronchial
secretions, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>, and accommodation; cause dilation
of the pupil; and may affect the heart rate.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE:</h1>
<p class="First">This
product is indicated for the temporary
relief of symptoms associated with seasonal and<br>perennial
allergic and non-<span class="product-label-link" type="condition" conceptid="257007" conceptname="Allergic rhinitis">allergic rhinitis</span>, and <span class="product-label-link" type="condition" conceptid="4283893" conceptname="Sinusitis">sinusitis</span>.Chlorpheniramine
Maleate temporarily relieves <span class="product-label-link" type="condition" conceptid="4170297" conceptname="Sniffles">runny nose</span><br>and
reduces <span class="product-label-link" type="condition" conceptid="4328356" conceptname="Sneezing">sneezing</span>, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span> of the nose or throat, and <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itchy</span>,watery
eyes due to <span class="product-label-link" type="condition" conceptid="256439" conceptname="Allergic rhinitis due to pollen">hay fever</span> or other upper respiratory<br>allergies.
Scopolamine Methyl Nitrate further augments the anti-secretory
activity of this product.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS:</h1>
<p class="First"></p>
<p>This
product is contraindicated in patients
with <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> or idiosyncrasy to any of its<br>ingredients.
It is also contraindicated in women who are pregnant
or nursing.</p>
<p>It is
also contraindicated in newborn or premature infants, because
this age group has an increased susceptibility to the<br>anticholinergic
side effects of chlorpheniramine maleate. Geriatric patients
may be more sensitive to the effects of this medication.</p>
<p>Risk-benefit
should be considered when the following conditions
exist: Acute <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>; <span class="product-label-link" type="condition" conceptid="433813" conceptname="Bladder neck obstruction">Bladder neck obstruction</span>;<br>Brain
damage in children; Cardiac disease, especially <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>,
<span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, <span class="product-label-link" type="condition" conceptid="317576" conceptname="Coronary arteriosclerosis">coronary artery disease</span>,<br>and
<span class="product-label-link" type="condition" conceptid="315273" conceptname="Mitral valve stenosis">mitral stenosis</span>; Cardiovascular disease; <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">Diabetes</span> mellitus;
Down’s Syndrome; <span class="product-label-link" type="condition" conceptid="30753" conceptname="Esophagitis">Esophagitis</span>, reflux; Narrow angle<br><span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>;
Acute <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhage</span> with unstable cardiovascular status;
Hepatic function impairment; <span class="product-label-link" type="condition" conceptid="199860" conceptname="Hernia of abdominal cavity">Hernia</span>; <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">Hypertension</span>;<br><span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">Hyperthyroidism</span>;
Intestinal atony in the elderly or debilitated patient;
Chronic <span class="product-label-link" type="condition" conceptid="257907" conceptname="Disorder of lung">lung disease</span>; <span class="product-label-link" type="condition" conceptid="76685" conceptname="Myasthenia gravis">Myasthenia gravis</span>; Autonomic<br><span class="product-label-link" type="condition" conceptid="197608" conceptname="Peripheral neuritis in pregnancy">neuropathy</span>;
<span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">Paralytic ileus</span>; <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">Prostatic hypertrophy</span>; Psychiatric disorders;
Pyloric obstruction; Renal function impairment;<br>Spastic
<span class="product-label-link" type="condition" conceptid="440377" conceptname="Paralysis">paralysis</span>, in children; <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">Tachycardia</span>; <span class="product-label-link" type="condition" conceptid="439393" conceptname="Pre-eclampsia">Toxemia of pregnancy</span>;
<span class="product-label-link" type="condition" conceptid="81893" conceptname="Ulcerative colitis">Ulcerative colitis</span>; <span class="product-label-link" type="condition" conceptid="192450" conceptname="Retention of urine">Urinary retention</span>, or<br>predisposition
to; Uropathy; <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">Xerostomia</span>.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<h1>WARNINGS:</h1>
<p class="First">This
product may cause <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> or <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>.
Patients taking this product should be warned not to<br>engage
in activities requiring mental alertness such as operating
a motor vehicle or other machinery or to perform<br>hazardous
tasks while taking this drug.</p>
<p><span class="Bold">Do
not exceed recommended dosage.</span></p>
<p></p>
<p>Heat
<span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">prostration</span> can occur with the use of scopolamine methyl
nitrate when the environmental temperature is high.<br><span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span>
may be an early symptom of incomplete <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">intestinal obstruction</span>,
especially in patients with ileostomy or<br>colostomy;
in this instance, use of scopolamine methyl nitrate would
be inappropriate and possibly harmful.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>PRECAUTIONS:</h1>
<p class="First"><span class="Bold">General:
</span>Antihistamines have an atropine-like
action and should be used with caution in<br>patients
with a history of bronchial <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, <span class="product-label-link" type="condition" conceptid="4169883" conceptname="Emphysema">emphysema</span>, increased
intraocular pressure, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>,<br>cardiovascular
disease and <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>.</p>
<p>Use
scopolamine methyl nitrate with caution in patients with
<span class="product-label-link" type="condition" conceptid="4224004" conceptname="Hiatal hernia">hiatal hernia</span> associated with <span class="product-label-link" type="condition" conceptid="30437" conceptname="Gastro-esophageal reflux disease with esophagitis">reflux Esophagitis</span>. Use<br>extreme
caution and only when needed in patients with autonomic
<span class="product-label-link" type="condition" conceptid="197608" conceptname="Peripheral neuritis in pregnancy">neuropathy</span>, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, coronary heart<br>disease,
<span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, and <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmia</span>.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-7"></a><p></p>
<h1>Information for patients:</h1>
<p class="First">Patient
consultation should include the following information
regarding proper use of this medication:<br>• Do
not take more medication than the amount recommended.<br>•
This medication should be used with caution during exercise
or hot weather, overheating may result in heat<br><span class="product-label-link" type="condition" conceptid="381316" conceptname="Cerebrovascular accident">stroke</span>.<br>• Do
not drive or operate machinery if <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> or <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>
occurs.<br>• Do
not ingest alcoholic beverages, monoamine oxidase
(MAO) inhibitors, or <span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span> producing<br>medications
(hypnotics, sedatives, tranquilizers)
while taking this medication.<br>•
This medication possibly increases sensitivity of eyes to
light.<br>•
Scopolamine methyl nitrate may cause <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>.<br>• If
a dose is missed, the medication should be taken as soon
as possible unless it is almost time for the next<br>dose.
Do not double dose.</p>
<p>Caution
patients about the signs of potential side effects,<br>especially:<br>•
Anticholinergic effects – <span class="product-label-link" type="condition" conceptid="4320789" conceptname="Clumsiness">clumsiness</span> or <span class="product-label-link" type="condition" conceptid="4046907" conceptname="Dysequilibrium syndrome">unsteadiness</span>;severe
<span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>; severe dryness of mouth, nose, or<br>throat;
<span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span> or <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span> of face; <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">shortness of breath</span> or
trouble breathing.<br>•
<span class="product-label-link" type="condition" conceptid="40528016" conceptname="Disorder of hematopoietic system">Blood dyscrasias</span>-<span class="product-label-link" type="condition" conceptid="26711" conceptname="Chronic pharyngitis">sore throat</span> and <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>; unusual <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span>
or <span class="product-label-link" type="condition" conceptid="441737" conceptname="Contusion">bruising</span>; unusual <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">tiredness</span> or <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>.<br>•
Fast or irregular heartbeat.<br>•
<span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">Psychotic episodes</span>.<br>•
<span class="product-label-link" type="condition" conceptid="4133044" conceptname="Chest discomfort">Tightness in chest</span>.</p>
<p></p>
<p><span class="Bold">Note:
</span>When anticholinergics are given to patients, especially
children, where the environmental temperature<br>is
high there is a risk of a rapid increase in body temperature
because of suppression of sweat gland<br>activity.
Infants, patients with Down’s syndrome, and children
with <span class="product-label-link" type="condition" conceptid="4300746" conceptname="Spastic paralysis">spastic paralysis</span> or <span class="product-label-link" type="condition" conceptid="4080670" conceptname="Brain damage">brain damage</span> may show<br>an
increased response to anticholinergics, thus increasing the
potential for side effects.</p>
<p>Geriatric
or debilitated patients may respond to usual doses
of anticholinergics with <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">excitement</span>, <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>,<br><span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>,
or <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="section-8"></a><p></p>
<h1>Laboratory Tests:</h1>
<p class="First"></p>
<p>The
following may be especially important
in patient monitoring (other tests may be<br>warranted
in some patients, depending on conditions): Blood
pressure determination – recommended at<br>frequent
intervals during therapy: Electrocardiogram (ECG)
– monitoring may be required: Intraocular<br>pressure
determination – recommended at periodic intervals,
as these medications may increase the<br>intraocular
pressure.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-9"></a><p></p>
<h1>Drug Interactions:</h1>
<p class="First">Do
not take this product if you are presently
taking, or have taken within the preceding<br>two
weeks, a prescription drug for high blood pressure or
<span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> without first consulting your physician.<br>Absorption
of other oral medications may be decreased
during concurrent use with anticholinergics<br>due
to decreased gastrointestinal motility and delayed gastric
emptying.</p>
<p></p>
<p>Combinations
containing any of the following medications,
depending on the amount present, may<br>also
interact with this product:<br>•
Alkalizers, such as: calcium and/or magnesium-containing
antacids; Carbonic inhibitors;<br>citrates;
sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span>-urinary excretion of anticholinergics
may be delayed by alkalization of the<br>urine,
thus potentiating scopolamine methyl nitrate therapeutic
and/or side effects.<br>•
Antacids or adsorbent antidiarrheals-simultaneous use
of these medications may reduce absorption of<br>scopolamine
methyl nitrate, resulting in decreased therapeutic
effectiveness; doses of these should be<br>spaced
2 or 3 hours apart from doses of scopolamine
methyl nitrate.<br>•
Anticholinergics – Concurrent use with anticholinergic effects;
patients should be advised to report<br>occurrence
of gastrointestinal problems promptly since paralytic
<span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">ileus</span> may occur with concurrent therapy.<br>• CNS
Depressants – Concurrent use of alcohol, antihistamines
with alcohol, tricyclic antidepressants,<br>barbiturates
and other CNS depressants may have an additive
effect.<br>•
Ketoconazole – Anticholinergics may increase gastrointestinal
pH, possibly resulting in a marked<br>reduction
in ketoconazole absorption during concurrent
use with anticholinergics; patients should be
advised<br>to take these medications at least 2 hours after
ketoconazole.<br>• MAO
inhibitors – Concurrent use may prolong and intensify
cardiac stimulate and vasopressor effects of<br>chlorpheniramine,
resulting in <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>,
<span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> or sudden and severe<br>hypertensive
and/or hyperpyretic crisis. These medications
should not be administered during<br>or
within 14 days following the administration of MAO inhibitor
therapy.<br>•
Metoclopramide – Concurrent use of metoclopramide with
anticholinergics may antagonize<br>metoclopramide’s
effects on gastrointestinal motility.<br>•
Potassium chloride – Concurrent use with anticholinergics
may increase the severity of<br>potassium
chloride-induced gastrointestinal lesions.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-10"></a><p></p>
<h1>Carcinogenesis, Mutagenesis, Impairment of Fertility </h1>
<p class="First"></p>
<p><span class="Bold"></span>No data
is available on the long-term potential of the components
of this product for Carcinogenesis, Mutagenesis or
Impairment of Fertility in animals or humans.</p>
<p><br></p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-11"></a><p></p>
<h1>Pregnancy:</h1>
<p class="First"><span class="Italics">Category
C: </span>It is not known whether Ryneze®
Liquid can cause fetal harm when administered<br>to a
pregnant woman or can affect reproduction capacity.
Ryneze® Liquid should be given to a pregnant<br>woman
only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-12"></a><p></p>
<h1>Nursing Mothers:</h1>
<p class="First"></p>
<p>It is
not known whether this drug is excreted
in human milk. Because many drugs are excreted<br>in
human milk, caution should be exercised when Ryneze Liquid
is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-13"></a><p></p>
<h1>Pediatric Use:</h1>
<p class="First">Safety
and effectiveness of Ryneze® Liquid in
children below the age of 6 have not been established.</p>
<p>Use
is not recommended for children under six years of age.
A paradoxical reaction characterized by<br><span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">hyperexcitability</span>
may occur in children taking large doses
of anticholinergics.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="section-14"></a><p></p>
<h1>Geriatric Use:</h1>
<br><p class="First">Geriatric
patients may respond to usual doses
of anticholinergics with <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">excitement</span>, <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>,<br><span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>,
or <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>. Geriatric patients are especially
susceptible to the anticholinergic side effects,<br>such
as <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, dryness of the mouth, and <span class="product-label-link" type="condition" conceptid="192450" conceptname="Retention of urine">urinary retention</span>
(especially in males). If these side effects occur<br>and
continue or are severe, medication should probably be
discontinued.</p>
<p></p>
<p>Caution
is also recommended when anticholinergics are given
to geriatric patients, because of the danger of<br>precipitating
undiagnosed <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>. Memory may become
severely impaired in geriatric patients, with the<br>continued
use of anticholinergics, since these drugs block
the action of acetylcholine, which is responsible for<br>many
functions of the brain, including memory function.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-15"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>
<p class="First"></p>
<p>The
following adverse reactions have
been observed with the use of chlorpheniramine and<br>scopolamine
methyl nitrate; Arrhytmias, <span class="product-label-link" type="condition" conceptid="40528016" conceptname="Disorder of hematopoietic system">blood dyscrasias</span>, CNS
<span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, CNS stimulation, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>,<br>dryness
of mouth, <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>,
increased <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>, loss of appetite,<br>paradoxical
reaction, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span>, <span class="product-label-link" type="condition" conceptid="4152197" conceptname="Stomach ache">stomach upset</span>
or <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>, thickening of mucus, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">tingling</span> in hands or<br>feet,
<span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">trembling</span>, troubled breathing, unusual <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">tiredness</span> or <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>,
<span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>.</p>
<p><span class="Bold">Note:
</span><span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">Agitation</span>; <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>; difficult or <span class="product-label-link" type="condition" conceptid="197684" conceptname="Dysuria">painful urination</span>; <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>;
<span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>; and dryness of mouth, nose and<br>throat
are more likely to occur in the elderly. <span class="product-label-link" type="condition" conceptid="4009184" conceptname="Dream anxiety disorder">Nightmares</span>,
unusual <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">excitement</span>, <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>,<br><span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>,
or <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span> are more likely to occur in children
and the elderly. When anticholinergics are given<br>to
patients, especially children, where the environmental temperature
is high, there is risk of a rapid increase in<br>body
temperature.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-16"></a><p></p>
<h1>OVERDOSAGE:</h1>
<p class="First">In
all cases of suspected <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, immediately
call your regional poison center and/or<br>contact
a physician immediately. The stomach should be emptied
promptly by lavage or induction of <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span> with<br>syrup
of ipecac. The installation of activated charcoal into he
stomach also should be considered. The treatment of<br><span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>
is essentially sypmptomatic and supportive. If respiratory
<span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> is present treat promptly with oxygen
and/or<br>mechanical support of ventilation. If <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>
or marked CNS <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">excitement</span> occurs, only short-acting
benzodiazepine-type<br>drugs should be used.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-17"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>
<p class="First"><span class="Bold">Adults
and children 12 years of age and older:</span></p>
<p>1
teaspoonful (5 mL) every 4 to 6 hours, not to exceed 6
teaspoonfuls in 24 hours.</p>
<p></p>
<p><span class="Bold">Children
6 to under 12 years of age:</span><span class="Bold"><br></span></p>
<p>½ teaspoonful (2.5
mL) every 4 to 6 hours, not to exceed 3
teaspoonfuls in 24 hours.</p>
<p></p>
<p>RYNEZE®
LIQUID is not recommended for children under
6 years of age.</p>
<p></p>
<p><span class="Bold">Note:</span>Geriatric patients may be more sensitive to the effects of
the usual adult dose. Adjust adult dose accordingly.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-18"></a><p></p>
<h1>HOW SUPPLIED:</h1>
<br><p class="First">RYNEZE®
LIQUID is supplied as a clear,
grape-flavored liquid, dye free, sugar free, alcohol<br>free,
and gluten free in 16 fl oz (473 mL) bottles, NDC
24839-346-16, and 10 mL sample,<br>NDC
24839-346-10<span class="Bold"></span></p>
<span class="Bold"><br>KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL<br><span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">OVERDOSE</span>, CALL A DOCTOR OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.<br></span><p><span class="Bold">Pharmacist:</span> Store at controlled room temperature, 15°-30°C
(59°-86°F). Avoid exposure to heat. Dispense<br>in a
tight, light-resistant container as defined in
the USP/NF with a child-resistant closure.</p>Manufactured For:<br>SJ pharmaceuticals<br>4200 Northside Pkwy NW, <br>Building 12<br>Atlanta, GA 30327<br><br>Manufactured By:<br>Great Southern Laboratories<br>Houston, TX 77099<br><br>Rev. 06/09<br><span class="Bold"><span class="Bold"><span class="Bold"><span class="Bold"></span></span></span></span>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-19"></a><p></p>
<h1>PRODUCT PACKAGING:</h1>
<p class="First">The packaging below represents the labeling currently used.</p>
<p><span class="Bold">Ryneze</span><span>®</span><span class="Bold"> Liquid</span></p>
<p><span class="Bold">Antihistamine/Anticholinergic</span></p>
<p>Each
5 mL (one teaspoonful) for oral<br>administration
contains:<br>Chlorpheniramine
Maleate ...... 4 mg<br>Scopolamine
Methyl Nitrate .... 1.25 mg</p>
<p>Rx Only</p>
<p>Dye Free/Sugar Free<br>Alcohol Free/Gluten Free<br>Grape Flavor<br>16 fl oz (473 mL)<br></p>DOSAGE AND ADMINISTRATION:<br>Adults and children 12 years of age and older:<span class="Bold"></span>1 teaspoonful (5 mL) every 4 to 6 hours, not to exceed 6 teaspoonfuls in 24 hours.<br>Children 6 to under 12 years of age:<span class="Bold"><br></span>1/2 teaspoonful (2.5 mL) every 4 to 6 hours, not to exceed 3 teaspoonfuls in 24 hours.<br>RYNEZE<span>®</span> LIQUID is not recommended for children under 6 years of age.<br><br>THIS BOTTLE IS NOT TO BE DISPENSED TO THE CONSUMER.<br><span class="Bold"><br></span>Note<span class="Bold">: </span>Geriatric patients may be more sensitive to the effects of the usual adult dose. Adjust adult dose accordingly. <br><br>KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">OVERDOSE</span>,<br>CALL A DOCTOR OR CONTACT A POISON CONTROL CENTER IMMEDIATELY. <br><br>Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.<br><span class="Bold"><br></span>Pharmacist:<span class="Bold"><span class="Bold"><span class="Bold"></span></span><span class="Bold"></span></span>Store at controlled room temperature, 15<span class="Sup">o</span>-30<span class="Sup">o</span>C (59<span class="Sup">o</span>-86<span class="Sup">o</span>F). Avoid exposure to heat. Dispense in a <br>tight, light-resistant container as defined in the USP/NF with a child-resistant closure. <br><span class="Bold"><br></span>Manufactured for:<br>SJ Pharmaceuticals<br>4200 Northside Parkway, NW<br>Building 12<br>Atlanta, GA 30327<span class="Bold"><br><br></span>Manufactured by:<br>Great Southern Laboratories<br>Houston, TX 77099<br><br>Rev. 06/09<br><span class="Bold"><span class="Bold"><span class="Bold"><br></span></span></span><div class="Figure"><img alt="Ryneze packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9aca3d25-d042-479b-a00e-63be5b5073fe&amp;name=MM1.jpg"></div>
<br><div class="Figure"><img alt="Ryneze packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9aca3d25-d042-479b-a00e-63be5b5073fe&amp;name=MM2.jpg"></div>
<br><div class="Figure"><img alt="Ryneze Packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9aca3d25-d042-479b-a00e-63be5b5073fe&amp;name=MM3.jpg"></div>
<br><div class="Figure"><img alt="Ryneze packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9aca3d25-d042-479b-a00e-63be5b5073fe&amp;name=MM4.jpg"></div>
<br><div class="Figure"><img alt="Ryneze packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9aca3d25-d042-479b-a00e-63be5b5073fe&amp;name=MM5.jpg"></div>
<br><div class="Figure"><img alt="Ryneze packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9aca3d25-d042-479b-a00e-63be5b5073fe&amp;name=MM6.jpg"></div>
<br><div class="Figure"><img alt="Ryneze packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9aca3d25-d042-479b-a00e-63be5b5073fe&amp;name=MM7.jpg"></div>
<br>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>RYNEZE LIQUID 		
					</strong><br><span class="contentTableReg">chlorpheniramine maleate, scopolamine methyl nitrate liquid</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:24839-346</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Chlorpheniramine Maleate</strong> (Chlorpheniramine) </td>
<td class="formItem">Chlorpheniramine Maleate</td>
<td class="formItem">4 mg  in 5 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>Methscopolamine Nitrate</strong> (Methscopolamine) </td>
<td class="formItem">Methscopolamine Nitrate</td>
<td class="formItem">1.25 mg  in 5 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">    </td>
<td class="formLabel">Score</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem">GRAPE</td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:24839-346-10</td>
<td class="formItem">6  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:24839-346-10</td>
<td class="formItem">10 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:24839-346-16</td>
<td class="formItem">473 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved other</td>
<td class="formItem"></td>
<td class="formItem">07/09/2009</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>SJ Pharmaceuticals, LLC
							(845662720)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Great Southern Laboratories (056139553)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Great Southern Laboratories</td>
<td class="formItem"></td>
<td class="formItem">056139553</td>
<td class="formItem">manufacture</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 7/2009<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>2251d5a4-6d02-4fbb-8872-7c1e19585d7a</div>
<div>Set id: 9aca3d25-d042-479b-a00e-63be5b5073fe</div>
<div>Version: 1</div>
<div>Effective Time: 20090707</div>
</div>
</div> <div class="DistributorName">SJ Pharmaceuticals, LLC</div></p>
</body></html>
